68Ga-Pentixafor as radio ligand for CXCR4 has been proven an alternative to 18F- fluorodeoxyglucose (FDG) PET, showing clearly higher detection rates and a better tumour-to-background contrast [29]. This evidence concerns the gene CXCR4 and neoplasm.